Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142900 |
| CAS No | NA |
| Mol.F. | C20H24N8O7 |
| Mol.Wt. | 488.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142901 |
| CAS No | 29291-35-8 |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142902 |
| CAS No | 77313-99-6 |
| Mol.F. | C19H22N8O7 |
| Mol.Wt. | 474.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142903 |
| CAS No | NA |
| Mol.F. | C7H4N6O4 |
| Mol.Wt. | 236.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142904 |
| CAS No | NA |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142905 |
| CAS No | NA |
| Mol.F. | C21H21N5O4 |
| Mol.Wt. | 407.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142906 |
| CAS No | NA |
| Mol.F. | C21H20N4O5 |
| Mol.Wt. | 408.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142907 |
| CAS No | NA |
| Mol.F. | C24H23N5O5 |
| Mol.Wt. | 461.48 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142908 |
| CAS No | NA |
| Mol.F. | C19H17N5O4 |
| Mol.Wt. | 379.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142909 |
| CAS No | NA |
| Mol.F. | C21H23N5O6 |
| Mol.Wt. | 441.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142910 |
| CAS No | NA |
| Mol.F. | C21H23N5O5 |
| Mol.Wt. | 425.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142911 |
| CAS No | NA |
| Mol.F. | C21H21N5O5 |
| Mol.Wt. | 423.43g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142912 |
| CAS No | NA |
| Mol.F. | C19H16N4O5 |
| Mol.Wt. | 380.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142913 |
| CAS No | NA |
| Mol.F. | C21H23N5O5 |
| Mol.Wt. | 425.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142914 |
| CAS No | NA |
| Mol.F. | C22H23N5O4 |
| Mol.Wt. | 421.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142915 |
| CAS No | NA |
| Mol.F. | C20H19N5O4 |
| Mol.Wt. | 393.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |